Autoimmune hemolytic anemia	phenotype	
Rituximab	drug	
Alemtuzumab	drug	
FCGR2B	drug_target	
C1S	drug_target	
Ipilimumab	drug	
Natalizumab	drug	
MS4A1	drug_target	
Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency	phenotype	
ITGA4	drug_target	
FCGR3A	drug_target	
CD52	drug_target	
C1R	drug_target	
MPO	drug_target	
C1QB	drug_target	
FCGR3B	drug_target	
PLA2G2E	drug_target	
C1QA	drug_target	
CHUK	drug_target	
ALOX5	drug_target	
GRB2	drug_target	
CTLA4	drug_target	
Pegademase Bovine	drug	
FCGR2A	drug_target	
FCGR1A	drug_target	
ICAM1	drug_target	
C1QC	drug_target	
Aminosalicylic Acid	drug	
FCGR2C	drug_target	
PTGS2	drug_target	
